Lactoferrin-Conjugated Nanoparticles as New Antivirals
Malgorzata Krzyzowska1, Martyna Janicka1,2, Emilia Tomaszewska3
1Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.
Pharmaceutics
|September 23, 2022
Summary
Lactoferrin, an iron-binding glycoprotein, shows broad-spectrum antiviral activity by directly targeting viruses or enhancing immune responses. Nanotechnology offers potential for developing novel, effective lactoferrin-based antiviral therapies.
Area of Science:
- Biochemistry and immunology
- Nanotechnology applications in medicine
Background:
- Lactoferrin is an iron-binding glycoprotein with diverse biological functions.
- It exhibits significant antiviral properties against DNA and RNA viruses.
- Lactoferrin's immunomodulatory effects are also of interest.
Purpose of the Study:
- To review the antiviral mechanisms of lactoferrin.
- To explore the potential of nanotechnology in developing lactoferrin-based antiviral drugs.
Main Methods:
- Literature review of lactoferrin's antiviral mechanisms.
- Exploration of nanotechnology-based approaches for drug development.
Main Results:
- Lactoferrin's antiviral activity stems from direct viral binding or immune system modulation.
- Nanotechnology can enhance the delivery and efficacy of lactoferrin as an antiviral agent.
Conclusions:
- Lactoferrin possesses multifaceted antiviral properties.
- Nanotechnology presents a promising avenue for creating advanced, safe, and effective lactoferrin-derived antiviral therapeutics.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...